There is nothing thats really all benefit and no risk
This regulatory effect is partly mediated via the AMPK/sirtuin-1 (SIRT1) axis, as knockdown of SIRT1 abrogated the lipid-lowering and autophagy-inducing effects of GLP-1RAs, highlighting a crucial role of this pathway in regulating lipid metabolism by facilitating degradation of lipid droplets, thus preventing excessive lipid accumulation (12)
These studies suggest that GLP-1RA may inhibit TCR signaling in a GLP-1R-dependent manner, thereby reducing systemic and intestinal inflammation induced by CD8 + T cells and other factors (anti-CD3 induction) (99)
This benefit is also supported by trials such as LEADER, SUSTAIN-6, and EXSCEL, in which the reduction in MACE was significant among those with established ASCVD
At this point, most patients have found the dose that produces meaningful weight loss while remaining tolerable long-term
Video Abstract Similar content being viewed by others Digital Features This article is published with digital features, including a video abstract to facilitate understanding of the article